285 related articles for article (PubMed ID: 21080168)
1. A prospective study to assess the predictive value for hereditary spherocytosis using five laboratory tests (cryohemolysis test, eosin-5'-maleimide flow cytometry, osmotic fragility test, autohemolysis test, and SDS-PAGE) on 50 hereditary spherocytosis families in Argentina.
Crisp RL; Solari L; Vota D; García E; Miguez G; Chamorro ME; Schvartzman GA; Alfonso G; Gammella D; Caldarola S; Riccheri C; Vittori D; Venegas B; Nesse A; Donato H
Ann Hematol; 2011 Jun; 90(6):625-34. PubMed ID: 21080168
[TBL] [Abstract][Full Text] [Related]
2. Comparison study of the eosin-5'-maleimide binding test, flow cytometric osmotic fragility test, and cryohemolysis test in the diagnosis of hereditary spherocytosis.
Park SH; Park CJ; Lee BR; Cho YU; Jang S; Kim N; Koh KN; Im HJ; Seo JJ; Park ES; Lee JW; Yoo KH; Jung HL
Am J Clin Pathol; 2014 Oct; 142(4):474-84. PubMed ID: 25239414
[TBL] [Abstract][Full Text] [Related]
3. A comparative evaluation of Eosin-5'-maleimide flow cytometry reveals a high diagnostic efficacy for hereditary spherocytosis.
Joshi P; Aggarwal A; Jamwal M; Sachdeva MU; Bansal D; Malhotra P; Sharma P; Das R
Int J Lab Hematol; 2016 Oct; 38(5):520-6. PubMed ID: 27339613
[TBL] [Abstract][Full Text] [Related]
4. Use of capillary blood to diagnose hereditary spherocytosis.
Crisp RL; Solari L; Gammella D; Schvartzman GA; Rapetti MC; Donato H
Pediatr Blood Cancer; 2012 Dec; 59(7):1299-301. PubMed ID: 22488885
[TBL] [Abstract][Full Text] [Related]
5. Experience with eosin-5'-maleimide as a diagnostic tool for red cell membrane cytoskeleton disorders.
Kedar PS; Colah RB; Kulkarni S; Ghosh K; Mohanty D
Clin Lab Haematol; 2003 Dec; 25(6):373-6. PubMed ID: 14641141
[TBL] [Abstract][Full Text] [Related]
6. Advances in laboratory diagnosis of hereditary spherocytosis.
Farias MG
Clin Chem Lab Med; 2017 Jun; 55(7):944-948. PubMed ID: 27837594
[TBL] [Abstract][Full Text] [Related]
7. Using the eosin-5-maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis.
King MJ; Telfer P; MacKinnon H; Langabeer L; McMahon C; Darbyshire P; Dhermy D
Cytometry B Clin Cytom; 2008 Jul; 74(4):244-50. PubMed ID: 18454487
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric osmotic fragility test: Increased assay sensitivity for clinical application in pediatric hematology.
Ciepiela O; Adamowicz-Salach A; Zgodzińska A; Łazowska M; Kotuła I
Cytometry B Clin Cytom; 2018 Jan; 94(1):189-195. PubMed ID: 28103644
[TBL] [Abstract][Full Text] [Related]
9. Utility of mean sphered cell volume and mean reticulocyte volume for the diagnosis of hereditary spherocytosis.
Arora RD; Dass J; Maydeo S; Arya V; Kotwal J; Bhargava M
Hematology; 2018 Aug; 23(7):413-416. PubMed ID: 29338606
[TBL] [Abstract][Full Text] [Related]
10. Toward the harmonization of result presentation for the eosin-5'-maleimide binding test in the diagnosis of hereditary spherocytosis.
Hunt L; Greenwood D; Heimpel H; Noel N; Whiteway A; King MJ
Cytometry B Clin Cytom; 2015 Jan; 88(1):50-7. PubMed ID: 25227211
[TBL] [Abstract][Full Text] [Related]
11. Rapid flow cytometric test for the diagnosis of membrane cytoskeleton-associated haemolytic anaemia.
King MJ; Behrens J; Rogers C; Flynn C; Greenwood D; Chambers K
Br J Haematol; 2000 Dec; 111(3):924-33. PubMed ID: 11122157
[TBL] [Abstract][Full Text] [Related]
12. [Hereditary spherocytosis: one year study of erythrocyte membrane proteins].
Tshilolo L; Kagambega F; Sztern B; Vertongen F; Gulbis B
Rev Med Brux; 1998 Oct; 19(5 Pt 1):417-23. PubMed ID: 9844481
[TBL] [Abstract][Full Text] [Related]
13. [Flow-assisted differential diagnosis of hemolytic anemia with spherocytosis: a case report].
Won DI
Korean J Lab Med; 2010 Aug; 30(4):339-44. PubMed ID: 20805704
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric osmotic fragility test and eosin-5'-maleimide dye-binding tests are better than conventional osmotic fragility tests for the diagnosis of hereditary spherocytosis.
Arora RD; Dass J; Maydeo S; Arya V; Radhakrishnan N; Sachdeva A; Kotwal J; Bhargava M
Int J Lab Hematol; 2018 Jun; 40(3):335-342. PubMed ID: 29573337
[TBL] [Abstract][Full Text] [Related]
15. Clinico-hematological profile of hereditary spherocytosis: experience from a tertiary care center in North India.
Kar R; Rao S; Srinivas UM; Mishra P; Pati HP
Hematology; 2009 Jun; 14(3):164-7. PubMed ID: 19490762
[TBL] [Abstract][Full Text] [Related]
16. [Microspherocytosis. Erythroid profile and its relation with different laboratory tests].
Aixála MT; Sarandría CN
Medicina (B Aires); 2001; 61(4):417-23. PubMed ID: 11563170
[TBL] [Abstract][Full Text] [Related]
17. Erythrocyte membrane protein defects in hereditary spherocytosis patients in Turkish population.
Ayhan AC; Yildiz I; Yüzbaşıoğlu S; Celkan T; Apak H; Ozkan A; Karaman S
Hematology; 2012 Jul; 17(4):232-6. PubMed ID: 22889517
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic power of laboratory tests for hereditary spherocytosis: a comparison study in 150 patients grouped according to molecular and clinical characteristics.
Bianchi P; Fermo E; Vercellati C; Marcello AP; Porretti L; Cortelezzi A; Barcellini W; Zanella A
Haematologica; 2012 Apr; 97(4):516-23. PubMed ID: 22058213
[TBL] [Abstract][Full Text] [Related]
19. Hereditary spherocytosis with normal osmotic fragility after incubation. Is the autohemolysis test really obsolete?
Fukagawa N; Friedman S; Gill FM; Schwartz E; Shaller C
JAMA; 1979 Jul; 242(1):63-4. PubMed ID: 448868
[TBL] [Abstract][Full Text] [Related]
20. Clinical and hematologic features of 300 patients affected by hereditary spherocytosis grouped according to the type of the membrane protein defect.
Mariani M; Barcellini W; Vercellati C; Marcello AP; Fermo E; Pedotti P; Boschetti C; Zanella A
Haematologica; 2008 Sep; 93(9):1310-7. PubMed ID: 18641031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
